Q1 2021 Marrone Bio Innovations Inc Earnings Call
Can you please remain on the line.
Yes.
[music].
Please standby.
Good day, and welcome to the Maroon and bio innovations first quarter 2021 earnings Conference call. Today's conference is being recorded and at this time I would like to turn the conference over to Linda Moore General Counsel. Please go ahead.
Good afternoon, everyone and thank you for joining our call and welcome to the <unk> 2021 first quarter earnings conference call from Arone bio innovations on the call today are CEO, Kevin He lash CFO, Sue Cheung and my T T N and senior Vice President of International sale.
<unk>.
If you would please refer to slide two I would like to remind you that this conference call may contain forward looking statements within the meaning of the safe Harbor provisions of the private Securities Litigation Reform Act of 1995 regarding management's future expectations plans project.
<unk> forecasts and prospects.
Certain material assumptions were applied and reaching these conclusions and making these statements. Therefore actual results could differ materially from those contained in our forward looking information.
Important factors that could cause differences are contained in the reports filed by the company with the Securities and Exchange Commission, including under the heading risk factors M DNA and elsewhere and the Companys Annual report quarterly report and other filings.
The company expressly disclaims any obligation to revise or update any guidance or other forward looking statements to reflect events or circumstances that may arise. After the date of this call.
After our remarks, we will hold a question and answer session I will now turn the call over to our CEO, Kevin He lash Kevin.
Thank you Linda and thanks to everyone joining us on the call today.
We are now one third of the way through the year and I would point to three key indicators that we will continue to define our success in 2021.
One we are progressing rapidly toward delivering breakeven on an adjusted EBITDA basis.
Our first quarter results support this financial target and.
Sue will provide more color on our numbers and a few minutes.
Two we're accelerating our commercial expansion on multiple fronts and Matti will provide an update on our global launch plans and the large acre row crops and three we intend to be the leader among our AG biological peers in terms of bringing sustainable products to the market.
And I'll speak in a moment to and important study. We recently published that supports this position.
If you would turn to slide three I'm very pleased with the start to 2021.
As we have noted before the first quarter is a seasonally slower period for us and one that is driven by our specialty crop business in the United States.
This foundational sector continues to deliver and we expanded our market presence in this high value segment.
We reported our 11th consecutive quarter of increased revenues and our 10th consecutive quarter of gross margins above 50%.
As we committed we are being judicious with our spending.
First quarter operating expenses declined on an absolute basis by 11% and the ratio of operating expenses to sales was 91%.
Both metrics are a testament to our ability to grow revenue and margins, while strategically managing costs, a feat not easily accomplished and any company.
If you would refer to slide four.
We believe this quarter was an early indicator of our capabilities and of our upward trajectory as we approach breakeven on an adjusted EBITDA basis, we remain highly committed to our core business and the specialty crop markets.
However, given the market size and global reach.
And soil applied products and the major row crops represent a tremendous opportunity for us.
We have been serving this market for just over four years and have grown our offerings from one product to five.
We are launching four new products. This year three of which are seed treatments and all four of which are targeted for use and the broad acre row crops.
Good news is that we have and established material presence the better news is that the opportunity ahead of us is larger than what we've already achieved.
Sustainability is at the core of our mission at MDI and our seed treatments are a big part of that story.
Since our inception, we have been at the forefront of the advancement of biological solutions, which today account for roughly one third of all of the active ingredients used in agriculture.
Our distribution partners and growers rely upon us to provide products that deliver industry, leading performance and returns on investment however.
However, now more than ever and they also expect us to supply products and advanced sustainable agriculture practices.
To that and we commissioned the climate impact study of our <unk> seed treatment, which we made public on may 6th.
A summary of the results as illustrated on slide five.
And we're extremely pleased to report that our seed treatment reduce greenhouse gas emissions by more than 85% and soybeans and corn when compared with conventional pesticides.
Conservatively for each million acres of soy or corn and treated with their product more than 1 million pounds of carbon dioxide emissions are reduced.
This is equal to the amount of carbon sequestered by nearly 600 acres of U S Forest land.
Not only is our seed treatment better for the environment. It is also safe for humans pollinators and aquatic life.
<unk> has been and will continue to be a key player and sustainable agriculture.
This study is further proof of our contribution towards producing food that is safe for the environment and beneficial organisms, while serving our customers' needs.
The foundation for our growth now and the future is the increasing demand for food that is produced with sustainable agricultural practices and.
<unk> is uniquely positioned to meet this need and consequently drive our growth and profitability, which will be rewarded in the marketplace and thus to our shareholders.
With that I'd like to turn the call over to Sue.
Thank you Kevin and good.
Good afternoon to everyone on the call.
If you turn to slide six.
Our performance a year to date give us confidence to raise our outlook for 2020 one.
We have increased our revenue growth forecast to the upper <unk> percent range and.
In line with our historical revenue CAGR.
In addition, we have raised our annual gross margin target to the upper 50% net range.
And which also reflect.
Our more positive outlook for the year.
We expect to keep operating expenses are flat, while ramping up and revenues and the margin.
Yes.
If you want to turn to slide seven let me point to some key results from the FERC quarter.
Revenues or 11 million, a 14% increase from the first quarter of last year.
And in line with our sales growth in 2020.
We increased our sales in specialty crops, such as fruits and vegetables, and this expanded market of use was the key driver of net growth in the quarter.
Gross profit increased at a greater rate than sales.
Benefiting from and improved absorption of manufacturing overhead and Michigan plant.
A favorable mix of high volume products.
We delivered a 25% and increase in gross profit to $7 million and a 540 basis point and improvement in gross margin to 63, 1%.
And in addition, we have started the year with a firm handle on costs.
Operating expenses declined 11% to $10 million from $11 2 million in the first quarter of 2020.
75% of our total expense reduction came from operational efficiencies.
And turning it and 5% was related to limited travel and on from that said because.
Because of COVID-19.
As the restrictions are lifted we expect that these travel expenses to return to normal levels going forward.
That said, we are committed to holding operating expenses and the 2020 and level plus inflation.
The first and the quarter net loss was $3 3 million as compared with net loss of $7 million in the first quarter of 2020.
Adjusted EBITDA was a loss of $1 two.
And $2 million and this quarter as compared with net loss of $3 7 million a year ago.
This was a significant progress when compared with the first quarter of last year.
And improvement in net net loss of 53% and adjusted EBITDA up 68%.
Cash used in operating activities improved by $1 3 million in the first quarter as compared with a use of cash in the first quarter last year.
This improvement was driven largely by the reduction in net net loss and the efficient use of working capital.
I want to remind you that we're in the net off 1 million upgrade of our manufacturing plant with the projected two year payback.
As Kevin noted and have a clear line of sight to bring NPI into a positive adjusted EBITDA position through a combination of a robust sales growth strong gross margins and disciplined cost management.
With sufficient cash to fund the company's ongoing operations will be.
And in addition, we continue to pursue strategic accretive acquisitions that could accelerate our growth even faster than our base case.
We're pleased with the start to the year and are confident in our ability to deliver greater value to our shareholders.
I would like to turn the call over to Marty now to discuss our commercial outlook.
Matti.
Thank you Sue.
And it's a pleasure to be butter vs conversation today.
As Kevin noted the market for seed and soil applied.
<unk> and the major row crops and broad acres is an exciting growth opportunities and for us.
Global seed treatment market is forecasted to grow at approximately 12% CAGR through 2025.
Our growth rate, however, and revenues from seed treatment over the past four years has been more than double of that the industry has had and we expect our outsized growth in this area to continue.
We are offering the right products at the right time and.
And four short years, we've expanded our seed treatment portfolio from one product to five products.
We expect MDI biological seed treatments will be used and approximately 11 million acres of soybean corn and cotton and the United States This year and.
And Europe, we anticipate more than 24 million acres of corn, and sunflower and rapeseed will be treated with products based on our <unk> technology into 2020 one planting season.
And if you would now turn to slide eight.
We're launching three new seed treatments in the EU market.
<unk> talked about and impact all of these products and have demonstrated significant returns on investments coupled with a favorable environmental profile. These products promote nutrient uptake encourage route development and improved crop quality and yield.
As an example impact is a product designed specifically for the use and cereal crops, such as wheat, Ryan and barley.
This product given the crops the head start that a growing season by promoting early establishment over winter and capabilities and overall plant health.
No cereals are the largest crop segment in Europe with more than 100 million acres planted annually and this is an exciting market expansion opportunity for us.
Our seed treatment portfolio is always evolving and we're continuing and developing next generation products that offer new levels of efficacy with better returns for our customers.
And one game and seed treatment is not just to get one acre but to have multiple synergistic seed treatments from each acre.
One such product and our pipeline and <unk> and enhanced version of our current insecticides and <unk> products offered as a seed treatment.
Research shows <unk> provides the same excellent level of protection against target pests and.
<unk> application levels.
We're currently wrapping up the work necessary to make the appropriate regulatory submissions as well as refining the fermentation and formulation work. This has the potential to be a blockbuster product that could add an estimated incremental $50 million and peak annual revenues.
And we're also introducing another plant health product pacesetter.
And the United States. This year sales are underway now and advance of the product being applied and the may to July timeframe, and soybeans corn and cotton.
Pay salaries and full year treatment that improves overall plant health and crop vigor and resold as increased yields and a six to one return on investment for growers.
We've added distribution and key growing areas for these crops and our and testing with other potential partners to expand our distribution for 2022.
If you would now turn to slide nine.
This is a preview of what's to come for MDI commercially.
Our demonstration program is extensive and we will come back more than 300 trials around the world. This year, we will be that testing, both crop protection and crop health products and both full year and frequent application.
And the geographic split is roughly 50 50 between North America, and the rest of the world with one quarter of the trials slated for South America.
The Latin American market is a wide open opportunity for us demand for biologicals is increasing and the region with an estimated market value of $1 billion.
And a projected CAGR of 11%.
South America and of course is well known for its expensive soybean corn and wheat production and so.
You can see on slide 10.
Okay.
The current outlook for increased planted acreage. This fall reflects stronger yields and higher prices all of which contributes to the growers economic health.
We have been working actively with some of the large seed companies and Brazil to demonstrate the efficacy and normal position of RC and applied biologicals, and we already have some orders in hand.
Our most recent large scaled Windsor corn data from the <unk> season shows that we're extremely competitive in the region with plant health products as well as our Biopesticide portfolio.
And other parts of Latin America, we continue to work with key regional partners to expand existing agreements and open new ones.
Last fall, we announced the partnership with Verizon and Baxter to distribute our leading full year plant health products, which they sell under the brand name and meet the growth.
Through this arrangement, we would expect to see more than 1 million acres treated already during 2021.
Strong planting prospects for winter crops, such as wheat, and barley should allow us to drive further demand going into 2022.
Now Pega rights and seats is another key distribution partner and Latin America BTG is already treating most of its forage crops seats with our pro forma technology we.
We had a successful launch event for <unk> technology, plus empty and pro during the first quarter and we will be expanding this premium seed treatment and multiple crops and Uruguay.
To conclude the agricultural forecast is for more experts and lower ending stocks this year, which in turn feeds higher prices and bullish forecast for planned and acres were and are fortunate position to be launching multiple new products and this environment.
We are doing so while simultaneously expanding our global footprint all of which allows us to increase our revenues and a faster pace than the AG industry as a whole.
With this I'd like to turn the call over to the operator now for your questions. Thank you.
Thank you and everyone to ask a question. Please press Star then one on your telephone keypad.
You're on a speakerphone, please pick up the handset or de press your mute function to allow that signal to reach our system.
Again that is star one to ask a question and we will go first to Sameer Joshi of H C. Wainwright.
Good afternoon, Thanks for taking my questions.
Congratulations on a good quarter.
You heard this metric that you have introduced a couple of quarters ago called the operating expense ratio.
It is a nicely trending at 91%.
And <unk>.
Of operating leverage or what level of.
How low can this school zone.
And.
Hi, Sameer its good to talk to you again, it's Kevin here.
So in terms of our operating expense ratio as an indicator to us of our gross profit trajectory. So in terms of how low can it go we continue to see our operating expenses trending at 2020 plus inflation.
And we're very fortunate and that at that level. We believe we can continue to drive the growth the topline growth and our company and the in the upper Twenty's and our gross margin rate in the upper fifties and so for continuing operations, we feel with that baseline is.
<unk> for us to move forward now.
I wouldn't say that day.
If we see an opportunity to invest and the company.
That will drive up our operating expenses that will drive our revenue and our gross margin posture, we will certainly take advantage of that opportunity but.
In terms of how low can that ratio go the faster we drive the topline Samir the lower that number is going to go and we and our objective is to make it as low as we can as quickly as our cam.
Understood.
In terms of gross margin youre targeting upper 50%.
You already have <unk> quarters of 63 plus percent.
Yes.
Gross margins are you expecting some.
Margin pressure and the next few quarters are you just being conservative and careful.
In terms of guidance.
Yes. Thank you Samira as Kevin again, so we've had a few quarters, where we've gone over 60% and we're obviously very happy with that achievement when we look out to the business the.
And to fluctuations in the quarters between our products and our geographies.
We think that it's going to bounce around and the upper Fifty's.
We may have a quarter, where it's a little higher we may have a quarter, where it's a little lower around that 60% range, but when we look out through the entire year. We think the upper <unk> is a good spot to.
Target our business set and Samir.
We remind you that we will have a bit of a headwind on our margins a slight headwind on our margins as we bring our Michigan plant online until we get it up to full operating capacity. So that's also weighs into our thinking as well.
Understood Yes.
Thanks for reminding us of that.
One of the things for the year's outlook includes the potential upside from strategic acquisitions.
That.
And yet in the month of May and all.
So it seems that there must be.
Walt is that Youre talking to.
And the advanced.
Do you have anything that you can share with the street and <unk>.
So what kind of acquisitions, we are looking at that could materialize and the mix of core five months.
Yes, Thank you Sameer and Kevin again.
So as we've mentioned in previous calls we believe the market is quite fragmented and there is an excellent opportunity out there for consolidation and I can also say that we are very active in terms of talking to potential partners for us moving forward.
And they are and all levels of.
Or stages of <unk>.
Discussion at this point we.
We don't have anything at at and advancing of space that we would reported but I can certainly tell you that we're active we're.
We're having some very interesting discussions with a number of different players, we see lots and lots of great opportunities and.
And I think it's going to be a matter for us of deciding which one do we want to chase when and in what sequence, but it's it's been a fun nine months I'd say in terms of getting to know the industry better and.
And seeking opportunities for us to accelerate our growth.
Understood.
I'll take the rest of my questions offline. Thanks, a lot.
Thanks Samir.
And our next question will come from and then cleave of Lake Street capital markets.
Alright, and thanks for taking my Hey, Kevin and thanks for taking my questions and congrats on a good quarter, especially on the bottom line here.
Few questions, one and the quarter and then a couple of Big picture questions. My quarterly question is is.
I'm trying to understand kind of the seasonality of your row crop business in North America in terms of first and second quarter breakdown.
Can you help me understand kind of the percentage of revenue recognition you expect and this market.
From the first quarter to the second quarter and how maybe that number has evolved and where you think it's and again I just don't understand the seasonality of this business as well as I should.
Okay.
No there and it's a very good question and thanks for asking it so.
In general and I'll speak in generality it and.
Ill comment a little bit about how things flow at least the way we see it.
So in terms of row crop and we start to seasonal with our seed treatment business and that goes on obviously at the very early stage of the cycle.
So that can happen for us in Q3 and into Q4 and the northern hemisphere, as we're getting ready for the planting season.
And then while that's all going on into Q1 and that becomes a big West coast market for US right now in terms of taking care of the specialty crops and trees are fruits and thats the <unk>.
The vegetables, and and as we move into Q2, and then we go back to row crops, Ben in terms of our foliar and soil applied treatments. So and then it really and on top of that and fluctuates depending on our customers' mood in terms of do they want to bring some product and early to stock up or.
Are they looking to wait a little bit longer and I would say Ben right now.
And we're certainly seeing good demand early.
For our products going into the row crop season and of course, we're having excellent prices and force the entire industry forecasting great crop input demand. So it's.
It's a bit tricky between Q1 and Q2, Ben but.
And I would say Q3 and Q4, but.
That's about how we see it a moored and happy to give you more color on that if that didn't answer your question.
No that was helpful. I appreciate there's a lot of variables kind of.
Working against each other at the same time, so that was helpful.
On a.
Couple of other Big picture question, you talked about the Latin American row crop opportunity, obviously, a huge addressable market for you all I know youre still and the relatively early stage here, but I'm wondering if you can talk about the contributions that this market.
How did your revenue and say 2020, and your expectations for that market this year and Nash.
And a percentage basis.
Yeah, Ben Thanks.
Great question so.
I'm going to hand, it over to Matti and a second but I can tell you that we are in.
Extremely positive about our potential in that market, we've got a.
A great Foundation in terms of our partners our distribution partners as Matti mentioned with <unk> and others. We've got.
I would say a healthy amount of field trials going on and we feel we've got a pipeline that fits to get into the market, they're not only and the specialty crops, where we've had our history, but really getting on the wheat corn and soybean acres in that market.
With that <unk> I'll hand, it over to you to this is one of your <unk>.
And here areas of greatest passions, and I'll hand, it over to you to provide bandwidth some more commentary on Latin America.
Yeah.
Yeah, Thanks, Kevin and thanks, Ben for the further questions matter here.
Yes.
Kevin is right there, so I think Latin American market as a whole.
<unk>.
One of my favorite charts and Theres many reasons wanted that.
And it's of course very big in terms and maybe it's also a very professional.
And and.
Free pragmatic, but as we've worked there already for a few years and in terms of product development and we've been working directly with our.
And hopefully future partners.
I'd say that right now we're at the breaking point, whereas the break through points right. So we have some big partnerships that we have.
Laid out like the original Baxter, one, but we for sure will have some more to comment and the very short future. So so it's taken some time and it always does.
We worked through and to demonstrate that both our bio pesticides and our plant health products are.
Not only competitive but but actually.
We're talking very competitive and and.
Good value for the growers and the whole channel and the and the market So and how we see the market is that is that Brazil is a market of its own and then you've got the rest of Latam, but but.
It definitely is.
It's something to look forward from all aspects and assets. We've been working there now long enough to be confident that we've got all the tools to breakthrough and the and the very short future.
Specifically with our row crop products, both and fee treatment and Samir.
Got it got it that's helpful. Thank you.
One other question from me and then I'll get back in queue, you talked about the carbon sequestration and <unk> product.
And I'm wondering about kind of a big picture question here.
Do you have studies like this.
Cross your product portfolio that really show the environmental benefits of the products from a carbon sequestration perspective, such that maybe your customers would have and easier access to the carbon markets.
As as they hopefully emerge here soon.
Yeah.
Ben Hi, it's Kevin again so.
We've spent you hit on a.
Very active topic and marron, we've spent a lot of time.
Talking about sustainability and of course, the impacted our products can have and do have and.
And so.
Being a science based and in fact based company. We wanted to have data alright, because we believe we are contributing positively but <unk>.
Show Me the numbers show me the independent assessment. So we went ahead and and.
Engage with boundless to do the study that we reported on.
And extremely happy with the results, we got a $9 eight out of 10 and and very very pleased with the results in terms of carbon sequestration greenhouse gas reduction by using our product and so that's given us the confidence band to continue down that path, we think that our 306 <unk>.
Alex as Matti mentioned is going to score extremely well.
And in that study as well and as we move forward and that's our intention is to continually provide data to our customers and to the market in terms of.
What benefits of our products have not only obviously they have to work create first and foremost they have to work they have to be efficacious. They have to provide a return for the grower, but and our opinion and when we can.
Add to that a fantastic sustainability story, we're really excited about that combination.
Got it.
Helpful as well.
Okay.
And I appreciate you taking my questions I think that does it from me I'll get back in queue.
Thanks Ben.
Our next question will come from Bobby Burleson with Canaccord.
Yes, good afternoon.
Alright, Hey, Kevin Thanks for taking my questions.
So a nice.
Nice quarter, especially on the profit line.
I'm curious just in terms of as you are.
<unk>.
Revenue mix and you're.
And products start to shift more and more we're continuing to shift more and more to row crops and seed and soil treatment.
What kind of a long term gains and and maybe operating expense efficiencies there might be out there just fundamentally trying to understand.
And how much more efficient spending and.
That area is versus specialty crops.
Hum.
Great question so.
Bobby and to be completely blunt and it's not.
Secret and were sub scale as many of and the industry are we built a platform here and this company that we can grow into it and I'm very fortunate.
To our investors and to Pam for building this platform and.
Certainly as we move into row crops getting on those massive acres in North America, and Europe, and Latin America and allows us to get to scale in terms of our production capacity in terms of utilizing our people in terms of all the infrastructure that is around.
This company so.
As Samir asked at the beginning.
And that kind of growth on the top line will drive down net operating ratio.
Opex ratio and make this company more profitable so.
Yes.
The more we focus and drive that topline revenue, while maintaining the infrastructure, we have which is right sized for the company.
It's going to certainly go right to the bottom line.
Okay, great. Thank you for that.
And then just.
I'll answer the previous caller.
Callers question on.
And the positive.
The result, and we got from <unk>.
The recent greenhouse gas.
Reduction.
<unk>.
Sure curious.
What kind of proactive next steps are and I understand that you can.
Moving ahead with similar studies on other products, but is there a larger kind of marketing package and you start to put together or.
There are groups that you.
Our more vocally apart.
Good.
Proactively move with customers and your direction the industry and their direction and how does that work.
Yes, Bobby.
We've spent quite a bit of time, it's Kevin again, and we've spent quite a bit of time talking about now what so we have this great result.
Fantastic reduction and greenhouse gas.
And by using our product and so who do we need to market that story too, obviously growers and obviously, our distribution channel partners, but who else right. So should it be the major food companies around the world.
Industry groups Consumer Association so.
You asked a great question and the short answer is yes.
We will be making a concerted effort to get the message out and right now our thinking is that net is going to be quite wide in terms of who do we talked with so we're very fortunate Keith Pitts as our chief sustainability Officer.
And he is spending the vast majority of his time right now working on this whole sustainability story for us because we think it's important for a number of reasons obviously.
First and foremost are good that we do or the or the the benefits we can provide with our products but.
I think we want to be or I know, we want to be one of the drivers of that getting that message out and the industry and talking about the features and benefits of AG Biologicals and general so and.
It will be a bigger and bigger and bigger part of our work here and marron bio.
Great and create maybe a tick tock.
Channel.
And something.
Something more gen.
Gen Z friendly.
Exactly okay, and we were lucky we've got a lot of we got a lot of those folks and accompany that.
Are much better at social media that I and Bobby.
Yes, I've got.
Like 10 from so.
Well, thanks again for the additional color I appreciate it.
Thanks, Bobby.
Okay.
And next we'll go to Nathan Weinstein of Aegis capital.
Okay.
Hi, Nathan Hi, Kevin Hi, Sue and Matt and Thanks for taking my question. So nice to see continued progress and the business and.
I suppose that.
Inflation has been a big topic recently and just maybe a broad take from you what youre, saying and agricultural industry from your own business from your customers in terms of inflation.
Yes, Nathan and Thats, a great question I mean, there's no doubt the prices of everything have gone up and there's no shortage of funny.
Funny.
Social media.
Posted about lumber prices to start with but in our industry obviously.
Higher grain prices is driving higher input costs.
But we still think that the.
Economic situation of the grower in general is and very good shape prices are fantastic and so while youre seeing and inflation in the input side.
Don't think that it has overcome the positive effects of the prices commodity prices and general from our side, Nathan and I imagine Youre thinking do we see any effect on our business.
At this point really we are feeling.
Pretty good tailwind.
We think that to high crop prices are going to drive a lot of crop inputs we have.
Going to see a healthy planted acres around the world. We believe that that will serve to MTL to distribution channel.
This year and set us up really nicely for 2022, and a restock and going to the market in the coming year with strong demand.
Certainly when our grower customers are doing well I mean, it's welcome everybody and the industry does well so.
I'd say at this point, while there is inflation.
And across almost everything you can think of I still think we're in good shape at least from our perspective, we are not feeling any negative impact at this time.
Oh, great good to hear.
And then another topic, that's been and the news lately and New York Legalizing marijuana and.
Maybe you can speak about your cannabis business any perspective on that part of the business.
Yes, Nathan so.
As you know we have a large number of our products that are certified organic.
And so they fit extremely well into that market and any organic market, including cannabis and.
I'd say, we think about it as a regular part of our crop portfolio.
We think we are we are a great fit there.
And as we do at any organic product so but.
We don't spend an inordinate amount of time.
Focusing on it.
We think about it is the same as any of our other organic crops and and I think that.
As that market continues to grow.
We expect to get our unfair share of that growth.
Great, Okay, very nice and that's fair. So I just wanted to close actually with the comment I was going to ask a sustainability question, but couple of other analysts document and I think that's a positive thing because I think that the sustainability aspect and morale and should be top of mind and the dialogue around their company. So as good day.
Here all of the interest on that front.
Yes, Thank you Nathan and thanks for taking a ton and joined the call today.
And with that that does conclude today's question and answer session and I would like to turn the call back to our spin speakers for any additional or closing comments.
Thank you operator.
We appreciate everybody's time today, and your interest and MBIA.
Our strong start to 2021 has given us the confidence to raise our forecast for this year.
And to a point.
To a time when we believe we will cross breakeven on an adjusted EBITDA basis the.
The strength of our commercial offerings globally, coupled with a continued focus on cost management will be key to our continued success and our ability to provide greater returns to our shareholders.
Thank you and we look forward to speaking with you again soon.
Okay.
And with that everyone that does conclude today's call we'd like to thank you again for your participation you may now disconnect.
[music].